Wall Street Fundamentals Releases New In-Depth Stock Reports on BSX, MDT, STJ and SYK

One of the most criticized components of the Affordable Care Act has been the medical device excise tax. The medical device excise tax places a 2.3 percent levy on the gross sales, not profit, of medical devices sold. Medical device manufacturers have argued that they will not obtain enough new customers from the overhaul of the U.S. healthcare sector to offset the higher costs. As a result a number of companies been forced to downsize and restructure. Major lobbying from the medical-device industry has factored into the Senate’s vote earlier this year to repeal the 2.3 percent tax.

Boston Scientific Corporation (NYSE: BSX) shares traded in the range of $9.19 to $9.45 Thursday before settling to close at $9.22, a decrease of 0.32 percent. The stock appears to be facing resistance at the $9.26 and $9.64 levels. The company is expected to release results for the second quarter of 2013 on July 24th. Shares of Boston Scientific have gained approximately 60.9 percent in 2013.

More information on Boston Scientific and access to the free equity report can be found at:
www.WallStreetFundamentals.com/BSX

Medtronic, Inc. (NYSE: MDT) shares traded in the range of $51.71 to $52.22 Thursday before settling to close at $51.93. The stock appears to be facing resistance at the $52.12 and $53.51 levels with some support at $51.08. According to a recent Bloomberg article, the company’s SynchroMed infusion pumps has been recalled after being linked to 14 patient deaths. Shares of Medtronic have gained approximately 26.6 percent in 2013.

More information on Medtronic and access to the free equity report can be found at:
www.WallStreetFundamentals.com/MDT

St. Jude Medical, Inc. (NYSE: STJ) shares traded in the range of $44.96 to $45.76 Thursday before settling to close at $45.65, an increase of 2.19 percent. The stock appears to be facing resistance at the $45.87 and $47.00 levels with some support at $44.91. Shares of St. Jude Medical have gained approximately 26.3 percent in 2013.

More information on St. Jude Medical and access to the free equity report can be found at:
www.WallStreetFundamentals.com/STJ

Stryker Corporation (NYSE: SYK) shares traded in the range of $64.55 to $65.06 Thursday before settling to close at $64.72 a share. The stock appears to be facing resistance at the $64.99 and $66.38 levels with some support at $64.39. Shares of Stryker have gained approximately 18.0 percent in 2013.

More information on Stryker and access to the free equity report can be found at:
www.WallStreetFundamentals.com/SYK

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com